Unlike conventional plans that may require insurers to approve certain outpatient services before beneficiaries receive care, the new option will remove the pre-approval requirement for eligible outpatient services.
France and its partners supported the construction and equipping of the clinic before handing it over to the Government of Liberia, the Ministry of Health, and the County Health Team.
Construction of the Hillsboro facility is expected to create about 200 jobs, with workers remaining on site through the project’s anticipated completion in 2031.
Siemens Healthineers will contribute US$5.4 million in cost sharing, bringing the total potential investment to US$36.5 million.
The new videoscope combines 4K, 3D and infrared (IR) imaging in a single device, allowing surgeons to switch between observation modes without changing scopes.
Previously, patients requiring tests unavailable at the hospital had to wait while their samples were transported to facilities in Mbarara.
The investment at Naivasha SEZ is expected to contribute to technology transfer, skills development and job creation while strengthening Kenya’s pharmaceutical manufacturing capacity.
Arya Pharma is implementing the Class II Type A recall in consultation with Sahpra and in accordance with the Medicines and Related Substances Act 101 of 1965, as amended.
The ICG will allocate 20,000 doses to a Phase 3 clinical trial designed to assess whether Ervebo can protect people against Bundibugyo virus.
The deal will give BioMarin access to ALE1, Alesta’s lead clinical-stage candidate for hypophosphatasia (HPP), a rare genetic bone disorder.